Bioabsorbable Surgical Fixation Devices Market Global Report 2026

The bioabsorbable surgical fixation devices market size has grown strongly in recent years. It will grow from $1.18 billion in 2025 to $1.24 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to the rising occurrence of orthopedic injuries and fractures, increasing demand for minimally invasive surgical interventions, growing preference for implants that avoid subsequent removal procedures, expanding adoption of biodegradable medical materials, and increasing emphasis on minimizing postoperative complications.

The bioabsorbable surgical fixation devices market size is expected to see strong growth in the next few years. It will grow to $1.56 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing demand for effective musculoskeletal tissue healing, growing adoption of bioabsorbable fixation technologies in sports medicine, rising need to enhance patient comfort following orthopedic procedures, expanding application of biodegradable fixation solutions for ligament and bone repair, and increasing demand to lower healthcare expenses associated with implant removal. Major trends in the forecast period include growing adoption of bioabsorbable fixation devices in orthopedic treatments, rising preference for temporary fixation solutions that avoid subsequent implant removal procedures, increasing use of biodegradable polymers for musculoskeletal tissue stabilization, growing demand for minimally invasive fixation techniques, and expanding adoption of bioabsorbable devices to support improved postoperative recovery.

The increasing demand for minimally invasive surgeries is expected to propel the growth of the bioabsorbable surgical fixation devices market going forward. Minimally invasive surgery refers to surgical procedures that use small incisions and specialized instruments to repair bone and soft tissue injuries. Minimally invasive surgeries are increasing due to growing patient preference for faster recovery, as these procedures reduce tissue damage, postoperative pain, hospital stays, and recovery time compared to conventional open surgeries. Bioabsorbable surgical fixation devices complement these procedures by providing temporary bone and soft tissue fixation without requiring a second surgery for implant removal, thereby reducing the overall patient burden while supporting efficient healing and improved clinical outcomes. For example, in June 2025, according to NHS England, a UK-based government department, around 70,000 robot-assisted minimally invasive surgeries were performed across the NHS in 2023-24. The NHS aims to increase this figure to 500,000 procedures annually by 2035, with 90% of eligible keyhole surgeries expected to be robot-assisted, reflecting the growing adoption of minimally invasive surgical techniques. Therefore, the increasing demand for minimally invasive surgeries is expected to drive the growth of the bioabsorbable surgical fixation devices market.

Leading companies operating in the bioabsorbable surgical fixation devices market are focusing on technological advancements in bioabsorbable polymers, such as bio-integrative mineral-fiber composite technology, to develop high-strength implants that promote bone integration, eliminate the need for implant removal surgeries, and improve long-term clinical outcomes. Bio-integrative mineral-fiber composite technology refers to the use of a composite material that combines bioactive mineral components with reinforcing fibers to create medical or surgical devices that can integrate with surrounding biological tissue. For example, in June 2025, OSSIO Inc., a US-based medical technology company, launched OSSIOfiber 2.5mm Suture Anchors. The anchors offer a smaller profile for procedures such as Brostrom repair, deliver 55% greater pull-out strength than the leading 2.4mm bio-composite anchor, and contain no metal, reducing the risk of adverse tissue reactions. This launch strengthens the soft tissue fixation portfolio and builds surgeon confidence in metal-free fixation, although high production costs continue to limit broader adoption.

In July 2024, Stryker Corporation, a US-based medical technology company offering orthopaedic implants, surgical equipment, neurotechnology, and spine solutions, acquired Artelon Inc. for an undisclosed amount. Through this acquisition, Stryker sought to reinforce its soft tissue fixation portfolio and broaden its comprehensive product offerings across the foot and ankle and sports medicine segments, strengthening its competitive standing in the wider bioabsorbable and biosynthetic fixation devices market. Artelon Inc. is a US-based company that develops soft tissue fixation products based on proprietary bioresorbable polymer technology, including systems used for ligament and tendon reconstruction.

Major companies operating in the bioabsorbable surgical fixation devices market are Johnson & Johnson, Stryker Corporation, Medtronic plc, Zimmer Biomet Holdings Inc, Smith & Nephew plc, Arthrex Inc, B Braun SE, CONMED Corporation, Gebrüder Martin GmbH & Co KG, Teijin Medical Technologies Co Ltd, Anika Therapeutics Inc, Acumed LLC, Gunze Limited, OSSIO Inc, Bioretec Ltd, Inion Oy, Osteopore International Pte Ltd, Jeil Medical Corporation, SBM SAS, Orthomed SAS, Matricel GmbH, Tulpar Medical Solutions.

North America was the dominating region in the bioabsorbable surgical fixation devices market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the bioabsorbable surgical fixation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioabsorbable surgical fixation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.